US › Healthcare

111 Inc (YI)

US · Healthcare · Medical Distribution

$3.54+4.73%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

$2.36B

Revenue YoY

-33.1%

Net profit

$-37.0M

EPS

$-0.26

Net margin

-1.6%

Key statistics

Market cap

$31.1M

Forward P/E

0.0

P/B

17.66

Book value

$-12.52

EPS (TTM)

$-7.69

52-week high

$8.53

52-week low

$2.48

50-day MA

$3.68

200-day MA

$5.10

Beta

0.65

Analyst view

with an average price target of $5.96.

Shareholding

Insiders

8.36%

Institutions

0.62%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	0.20%
Renaissance Technologies Corp	0.15%
Serenus Wealth Advisors, LLC	0.05%
Citigroup Inc	0.00%
SBI Securities Co Ltd	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
UBS Group AG	0.00%
JPMorgan Chase & Co	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for 111 Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.